Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2025-08-29 00:00:00 ET · period of report 2025-08-28 · accession 0001867096-25-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-29 | 2025-08-28 | XERS | SHERMAN JEFFREY W | Dir | M - OptEx | $6.66 | +47.0K | 261.4K | +22% | +$313.3K |
| D | 2025-08-29 | 2025-08-28 | XERS | SHERMAN JEFFREY W | Dir | S - Sale+OE | $7.92 | -42.2K | 219.2K | -16% | -$334.5K |
| D | 2025-08-29 | 2025-08-28 | XERS | SHERMAN JEFFREY W | Dir | M - OptEx | $0.00 | -47.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-28 | M | A | 47,040 | $6.66 | 261,420 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-28 | S | D | 42,232 | $7.92 | 219,188 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.920 to $7.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-08-28 | M | D | 47,040 | $0.00 | 0 | D | $6.66 · — to 2026-10-01 | 47,040 Common Stock | (F3) On October 1, 2016, the reporting person was granted an option to purchase shares of Strongbridge Biopharma plc ("Strongbridge") which were assumed by Issuer in connection with the acquisition of Strongbridge. The options vested in full on October 5, 2021. |